Capital Fund Management S.A. Viatris Inc Call Options Transaction History

Capital Fund Management S.A.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$10.32 - $12.13 $246,648 - $289,907	-23,900 Reduced 16.93%	117,300 $1.36 Million
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $1.71 Million - $2.04 Million	-169,900 Reduced 54.61%	141,200 $1.5 Million
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $1.58 Million - $1.9 Million	-140,100 Reduced 31.05%	311,100 $3.71 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $1.2 Million - $1.48 Million	-136,700 Reduced 23.25%	451,200 $4.89 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $412,370 - $488,050	-43,000 Reduced 6.82%	587,900 $5.8 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $4.27 Million - $4.87 Million	473,000 Added 299.56%	630,900 $6.3 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $1.45 Million - $1.94 Million	157,900 New	157,900 $1.52 Million
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $274,620 - $338,652	27,600 New	27,600 $288,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $159,655 - $217,807	-11,748 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $167,996 - $220,157	11,748 New	11,748 $220,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.